"The agency agreed that this was a minor Standard Operating Procedures (SOP) deviation that existed, was fully investigated, and all corrective actions were fully implemented by Mylan," the company's media release concluded, with appreciation for the FDA's quick action from company Chairman and CEO Robert J. Coury.
"People are being laid off from occupations where plants are moving out or closing down," said Matt Earnest, executive director of the Office of Workforce Development at the Community and Technical College at West Virginia University Institute of Technology.
